Novo Nordisk To Widen China Facilities For $100 Million, Add 50% To Staff
This article was originally published in PharmAsia News
Executive Summary
Novo Nordisk plans to spend $100 million expanding its research-and-development facility in China and increase its staff by more than 50%.